Abstract
The findings indicate that cefaclor-associated serum sickness-like reaction may be a unique adverse drug reaction that requires biotransformation of the parent drug and may be associated with inherited defects in the metabolism of reactive intermediates. The condition can be retrospectively confirmed with an in vitro lymphocyte-based cytotoxicity assay. This assay is specific for cefaclor and does not cross-react with cephalexin.
- Copyright © 1995 by the American Academy of Pediatrics
Individual Login
Log in
You will be redirected to aap.org to login or to create your account.
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
SERUM SICKNESS-LIKE REACTIONS TO CEFACLOR: ROLE OF HEPATIC METABOLISM AND INDIVIDUAL SUSCEPTIBILITY
Jump to section
Related Articles
Cited By...
- No citing articles found.